[Use of Runac in patients with infections of the lower respiratory tract].
Thirty patients went through the outpatient treatment. Causative agent was established in sputum, throat and nose smears of 26 patients. Streptococcus pneumoniae (56%) and Haemophilus influenze (30%) are mostly isolated. Good effects of the medicine is characteristic by quick withdrawal of the symptoms characteristic for respiratory tract infections (cough and expectoration, febrility, physical finding) as well as by debacillosis after 10 days therapy. The effective result of medicine has been particularly noticed through quick reduction until complete disappearance of expectoration after three to four days since the onset of treatment. No side effects of the medicine have been found.
Popovac
D
D
Gradski zavod za plućne bolesti i zastitu od tuberkuloze, Beograd.
Plavsić
Z
Z
Filipović
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae; D006801:Humans; D008297:Male; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D015575:Roxithromycin / Q000627:therapeutic use*
D015575:Roxithromycin
Primena Runaca u obolelih od infekcija donjih disajnih puteva.